Each week of the first 100 days of the new Trump administration, we will publish updates on key federal financial services regulatory and ...

Mosaic Therapeutics, Ltd (‘Mosaic’, or ‘the Company’) a targeted oncology therapeutics company dedicated to resolving ...

Mosaic Therapeutics Ltd, a targeted oncology therapeutics company dedicated to resolving cancer’s complexity with new ...

Syncona Limited Mosaic Therapeutics in-licences two clinical-stage assets from Astex Pharmaceuticals In-licensing these clinical-stage assets has significantly de-risked and accelerated Mosaic’s ...

The agency combined an office overseeing large banks with another looking after midsize and community banks. But merger news ...

Astex will also receive potential future revenue shares. Dr. Harren Jhoti, Co-founder, President and Chief Executive Officer of Astex, will also take an observer role on the Mosaic Board.

Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.

Otsuka Medical Devices is also taking some rights ... v=Im2dzqevces&ab_channel=GrayMattersHealth GrayMatters' chief executive Oded Kraft said that Prism is "the first digital therapeutic device ...

Atsuko Fukase formerly wrote about banking and M&A deals from The Wall Street Journal's Tokyo bureau.

Otsuka and Click Therapeutics’ Rejoyn has ... with MDD respond to the first medication tried. The company’s chief executive, David Benshoof Klein, said it “provides hope for those who ...

Palu, who is now the Pacific Catastrophe Risk Insurance Company (PCRIC) chief executive, was presenting his paper about various international funding that Tonga could tap into. He used his own ...

To keep you informed of recent activities, below are several of the most significant federal and state events that have influenced the ...